Under the partnership with Pfizer, Ultromics will research and pursue FDA clearance for its EchoGo Amyloidosis algorithm that already has Breakthrough…

Ultromics, a leader in the field of artificial intelligence-powered diagnostics for heart failure, has been granted FDA Breakthrough Device Status for…

Avalara, Inc., a leading provider of cloud-based tax compliance automation for businesses of all sizes, today announced the launch of Avalara…

- Company Expects to Initiate a Phase 1 Study in Early-Onset Alzheimer’s Disease in Early 2022, with Initial Human Data at or Around Year-End 2022 -…

Cowbell Arms Mylo Customers with Standalone, Admitted Cyber Coverage and Risk Insights Cowbell Cyber, the industry's first AI-powered cyber…

The anticipated acquisition aligns to GE HealthCare’s precision care strategy with the goal of strengthening the company’s digital solutions…

5 organizations receive funding to rigorously evaluate AI that improves patient care The Kaiser Permanente Augmented Intelligence in Medicine and…

Based on pioneering research from Mayo Clinic, ECG-AI LEF aims to aid physicians in identifying low ejection fraction in patients at risk of heart…

Alzheimer's disease is a critical neurological disorder that affects millions of people across the United States. It impacts the behavior, thinking,…

Hosting and colocation provider networks demonstrate a measurable performance advantage over in-house solutions, ISG Provider Lens report says…